Market Quick Take - December 23, 2021

Market Quick Take - December 23, 2021

Macro 6 minutes to read
Saxo Strategy Team

Summary:  New studies indicating less Omicron hospitalization from Scotland, South Africa and Denmark lifted market together with good Conference Board Consumer confidence data yesterday. It is still nervous trading and illiquidity continues. The revised Q3 data upped both GDP and the price indicators. GDPQ3 now at 2.3% while Price deflator is at 6%. Today's most important event is the US PCE inflation report for November.


What is our trading focus?

Nasdaq 100 (USNAS100.I) and S&P 500 (US500.I) - US equities continued their momentum yesterday with Nasdaq 100 futures hitting 16,170 up 1.2% on more positive Omicron studies on its hospitalization rate compared to the Delta variant.

Energy crisis (OIL:xmil) - US IEA reported higher than expected draws yesterday and combined with the positive Omicron studies crude oil pushed higher yesterday together with equities. The German Baseload Forward 1-year contract closed at a new all-time high yesterday at €315/MWh but is coming a bit off this morning in Europe despite an outlook for colder weather in Europe.

USDJPY - the cross broke above the recent local resistance level at 114.26 in yesterday’s session before retreating, but this morning the cross is following the risk-on sentiment higher sitting at this important resistance level.

Gold (XAUUSD) - just as the market was preparing for more sell-off with gold starting yesterday’s session pushing below the 200-day moving average, the stronger EURUSD helped gold turn around pushing through all key moving averages. Gold is trading around 1,806 this morning with the 1,814 level in sight (the recent highs) should EURUSD extending its momentum.

US Treasuries (SHY, IEF, TLT). The US 10-year yield is settling just below the 1.5% level before the crucial PCE inflation report for November out later today. If the PCE inflation figure surprises to the upside, then we could see the 10-year yield push firmly above the 1.5% level.

USDTRY – the cross is pushing lower in a short-term victory lap for the Turkish government that has implemented several unusual measures to deal with inflation, currency swings, and economic problems. USDTRY is trading 11.67 in early European trading with the 50-day moving average sitting at 11.51 which the cross has not been below since mid-September.

What is going on?

JD.com shares down 8% on Tencent divestment. Normally this time of the year is quiet in the markets, but Tencent put out a surprise today announcing that they are divesting their JD.com investment and issuing a special dividend of $16bn. The divestment should be seen as a response to the ongoing technology crackdown with the large technology companies beginning to disentangle themselves from each other.

Scottish study shows Omicron has two-thirds hospitalization risk compared to Delta. Another study showing signs that Omicron is less virulent, but in the short-term health authorities are saying that less virulent multiplied by higher contagiousness equal more pressure on hospitals. But looking beyond the next couple of weeks the news flow could positive supporting risk assets.

Amazon’s cloud business (AWS) is targeted by FTC. AWS has always been the golden egg for Amazon delivering most of its profits and is the definitive market leader in cloud infrastructure. The question has always been to what degree AWS is taking advantage of this position against customers and to what extent the high profit margin in AWS is used to subsidize the e-commerce business helping it keeping prices incredibly low hurting other retailers with no cloud business.

Pfizer’s Covid pill gets FDA approval. The US FDA granted emergency use authorization for Pfizer’s Covid pill, which is the first antiviral drug against the virus for at-home use. Pfizer’s shares rose 1% to $59.55.

Ryanair cuts fiscal year earnings guidance. Underscores the uncertainty and negative impact from Omicron in the medium-term. The news will likely impact the entire travel and leisure segment in Europe in today’s session.

What are we watching next?

It’s already Christmas in the markets. Thin liquidity and mainly event driven moves over the course of the day. We expect these conditions to continue this and next week as we enter the final week of the year. The year has been mixed and as such some rotation towards defensive will likely happen. We have full focus on energy prices as a culprit for more inflationary pressure.

PCE inflation report on Thursday. This is the key event this week and today’s PCE inflation report will likely show that inflationary pressures persisted throughout November and supporting the FOMC decision last week to end the wording “transitory inflation” and signaling faster tapering and a path to three rate hikes in 2022.

Earnings Watch – no earnings this week and will stay light until the Q4 earnings season starts in mid-January.

Economic calendar highlights for today (times GMT)

0900 – Italy Consumer Confidence Dec

1330 – US Initial and Continuing Claims

1330 – US Personal Spending Dec

1330 – US PCE Core Deflator Nov (The Fed’s measure of US inflation)

1330 – US Durable Goods Orders Nov

1500 – US New Home Sales

 

Follow SaxoStrats on the daily Saxo Markets Call on your favorite podcast app:

Apple Sportify Soundcloud Stitcher

Disclaimer

The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
Full disclaimer (https://www.home.saxo/legal/disclaimer/saxo-disclaimer)
Full disclaimer (https://www.home.saxo/legal/saxoselect-disclaimer/disclaimer)

Saxo Bank (Schweiz) AG
Beethovenstrasse 33
CH-8002
Zurich
Switzerland

Contact Saxo

Select region

Switzerland
Switzerland

All trading carries risk. Losses can exceed deposits on margin products. You should consider whether you understand how our products work and whether you can afford to take the high risk of losing your money. To help you understand the risks involved we have put together a general Risk Warning series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. The KIDs can be accessed within the trading platform. Please note that the full prospectus can be obtained free of charge from Saxo Bank (Switzerland) ltd. or the issuer.

This website can be accessed worldwide however the information on the website is related to Saxo Bank (Switzerland) Ltd. All clients will directly engage with Saxo Bank (Switzerland) Ltd. and all client agreements will be entered into with Saxo Bank (Switzerland) Ltd. and thus governed by Swiss Law.

The content of this website represents marketing material and has not been notified or submitted to any supervisory authority.

If you contact Saxo Bank (Switzerland) Ltd. or visit this website, you acknowledge and agree that any data that you transmit to Saxo Bank (Switzerland) Ltd., either through this website, by telephone or by any other means of communication (e.g. e-mail), may be collected or recorded and transferred to other Saxo Bank Group companies or third parties in Switzerland or abroad and may be stored or otherwise processed by them or Saxo Bank (Switzerland) Ltd. You release Saxo Bank (Switzerland) Ltd. from its obligations under Swiss banking and securities dealer secrecies and, to the extent permitted by law, data protection laws as well as other laws and obligations to protect privacy. Saxo Bank (Switzerland) Ltd. has implemented appropriate technical and organizational measures to protect data from unauthorized processing and disclosure and applies appropriate safeguards to guarantee adequate protection of such data.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc.